Claes Bergmark

2.5k total citations
20 papers, 2.0k citations indexed

About

Claes Bergmark is a scholar working on Immunology, Rheumatology and Surgery. According to data from OpenAlex, Claes Bergmark has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in Claes Bergmark's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Antioxidant Activity and Oxidative Stress (5 papers). Claes Bergmark is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Antioxidant Activity and Oxidative Stress (5 papers). Claes Bergmark collaborates with scholars based in Sweden, United States and Norway. Claes Bergmark's co-authors include Joseph L. Witztum, Elizabeth R. Miller, Sotirios Tsimikas, Sohvi Hörkkö, Ulf dé Fairé, Jesper Swedenborg, Mohammad Azam Mansoor, Asbjørn Svardal, Kihoon Han and Peter A. Friedman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Claes Bergmark

20 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claes Bergmark Sweden 13 1.0k 797 475 457 298 20 2.0k
John W. Gaubatz United States 27 526 0.5× 1.5k 1.9× 249 0.5× 216 0.5× 529 1.8× 42 2.7k
Carmen Bustos Spain 15 639 0.6× 570 0.7× 92 0.2× 74 0.2× 537 1.8× 24 2.3k
Mónica Ortego Spain 14 618 0.6× 939 1.2× 79 0.2× 85 0.2× 639 2.1× 20 2.3k
J O'Neil United States 13 316 0.3× 608 0.8× 49 0.1× 339 0.7× 224 0.8× 19 1.2k
Naeimeh Kamranpour United States 10 233 0.2× 541 0.7× 82 0.2× 135 0.3× 406 1.4× 11 1.5k
Kashif Jafri United States 10 252 0.2× 968 1.2× 254 0.5× 66 0.1× 308 1.0× 13 1.9k
Maria R. Oliva Spain 17 356 0.3× 347 0.4× 80 0.2× 98 0.2× 673 2.3× 25 1.9k
Jonathan Lu United States 17 479 0.5× 342 0.4× 46 0.1× 156 0.3× 243 0.8× 23 957
G. Bittolo‐Bon Italy 13 358 0.3× 786 1.0× 36 0.1× 456 1.0× 291 1.0× 20 1.5k
Elisabeth Koller Austria 23 312 0.3× 310 0.4× 106 0.2× 79 0.2× 481 1.6× 75 1.7k

Countries citing papers authored by Claes Bergmark

Since Specialization
Citations

This map shows the geographic impact of Claes Bergmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes Bergmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes Bergmark more than expected).

Fields of papers citing papers by Claes Bergmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claes Bergmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes Bergmark. The network helps show where Claes Bergmark may publish in the future.

Co-authorship network of co-authors of Claes Bergmark

This figure shows the co-authorship network connecting the top 25 collaborators of Claes Bergmark. A scholar is included among the top collaborators of Claes Bergmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claes Bergmark. Claes Bergmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuhuang, Hong Jin, Ljubica Perisic, et al.. (2017). Abstract 15313: Long Non-Coding RNA MIAT Regulates Smooth Muscle Cell Plasticity and Macrophage Activity in Advanced Atherosclerosis Lesions. Circulation. 1 indexed citations
2.
Li, Yuhuang, Hong Jin, Ljubica Perisic, et al.. (2016). Abstract 512: The Long Non-coding Rna MIAT Regulates Smooth Muscle Cell Proliferation and Macrophage Activity in Advanced Atherosclerotic Lesions. Arteriosclerosis Thrombosis and Vascular Biology. 36(suppl_1). 1 indexed citations
3.
Liu, Anquan, Roland Fiskesund, Ewa Ninio, et al.. (2014). Induction of Dendritic Cell–Mediated T-Cell Activation by Modified but Not Native Low-Density Lipoprotein in Humans and Inhibition by Annexin A5. Arteriosclerosis Thrombosis and Vascular Biology. 35(1). 197–205. 48 indexed citations
4.
Bergmark, Claes, Asheesh K. Dewan, Alexina Orsoni, et al.. (2008). A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. Journal of Lipid Research. 49(10). 2230–2239. 300 indexed citations
5.
Tsimikas, Sotirios, Stefan Kiechl, Johann Willeit, et al.. (2006). Oxidized Phospholipids Predict the Presence and Progression of Carotid and Femoral Atherosclerosis and Symptomatic Cardiovascular Disease. Journal of the American College of Cardiology. 47(11). 2219–2228. 160 indexed citations
6.
Tsimikas, Sotirios, Masanori Aikawa, Francis J. Miller, et al.. (2006). Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering. Arteriosclerosis Thrombosis and Vascular Biology. 27(1). 175–181. 61 indexed citations
7.
Tsimikas, Sotirios, Claes Bergmark, Reinaldo W. Beyer, et al.. (2003). Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. Journal of the American College of Cardiology. 41(3). 360–370. 293 indexed citations
8.
Edelstein, Celina, Ditta Pfaffinger, Elizabeth R. Miller, et al.. (2003). Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a). Journal of Biological Chemistry. 278(52). 52841–52847. 113 indexed citations
9.
Tsimikas, Sotirios, Herbert Lau, Claes Bergmark, et al.. (2003). 4P-0998 Pathophysiologic interrelationship of OxLDL and Lp(a) in human coronary plaque disruption and acute coronary syndromes. Atherosclerosis Supplements. 4(2). 294–294. 1 indexed citations
10.
Bannykh, Sergei I., Joseph L. Witztum, & Claes Bergmark. (2002). Mechanical Aortic Injury in apoE-Deficient Mice as a Model for Development of Atherosclerosis: Demonstration of Leukocyte Rolling Early After Injury. Ultrastructural Pathology. 26(4). 251–260. 3 indexed citations
11.
Mansoor, Mohammad Azam, Claes Bergmark, Peter H. Evans, et al.. (2000). Correlation between Plasma Total Homocysteine and Copper in Patients with Peripheral Vascular Disease. Clinical Chemistry. 46(3). 385–391. 52 indexed citations
12.
Nityanand, Soniya, et al.. (1999). Circulating Immune Complexes and Complement C4 Null Alleles in Patients Operated on for Premature Atherosclerotic Peripheral Vascular Disease. Journal of Clinical Immunology. 19(6). 406–413. 12 indexed citations
13.
Chang, Mi-Kyung, Claes Bergmark, Aino Laurila, et al.. (1999). Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proceedings of the National Academy of Sciences. 96(11). 6353–6358. 387 indexed citations
14.
Bergmark, Claes, Tomas Jogestrand, & Jesper Swedenborg. (1998). Carotid Atherosclerosis in Patients Operated for Lower Extremity Ischemia before the Age of 50: A Case Control Study. Annals of Vascular Surgery. 12(5). 430–435. 3 indexed citations
15.
Bergmark, Claes, Mohammad Azam Mansoor, Asbjørn Svardal, & Ulf dé Fairé. (1997). Redox Status of Plasma Homocysteine and Related Aminothiols in Smoking and Nonsmoking Young Adults,. Clinical Chemistry. 43(10). 1997–1999. 22 indexed citations
16.
Nityanand, Soniya, Claes Bergmark, Ulf dé Fairé, et al.. (1995). Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. Journal of Internal Medicine. 238(5). 437–443. 52 indexed citations
17.
Bergmark, Claes, Ruixin Wu, Ulf dé Fairé, Ann‐Kari Lefvert, & Jesper Swedenborg. (1995). Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL. Arteriosclerosis Thrombosis and Vascular Biology. 15(4). 441–445. 214 indexed citations
18.
Mansoor, Mohammad Azam, Claes Bergmark, Asbjørn Svardal, Per Eystein Lønning, & Per Magne Ueland. (1995). Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 15(2). 232–240. 183 indexed citations
19.
Bergmark, Claes, Mohammad Azam Mansoor, Jesper Swedenborg, et al.. (1993). Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50—effect of smoking and extent of disease. European Journal of Vascular Surgery. 7(4). 391–396. 58 indexed citations
20.
Bergmark, Claes, Gun Johansson, Pär Olofsson, & Jesper Swedenborg. (1991). Femoro-popliteal and femoro-distal bypass: a comparison between in situ and reversed technique.. PubMed. 32(1). 117–20. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026